Heart Valve Technology

This channel includes news and new device innovations about heart valve technologies, including the aortic valve, mitral valve, pulmonic valve, and tricuspid valve. This includes information on transcatheter valve technologies like transcatheter aortic valve replacement (TAVR, or implantation TAVI), transcatheter mitral valve replacement (TMVR), transcatheter and surgical valve repairs, ad surgical replacement valves.

Mayo Clinic uses the Da Vinci surgical robot to perform minimally invasive mitral valve surgeries.
News | Robotic Systems | January 20, 2020

January 20, 2020 — Research has found that repairing the mitral valve earlier, before the mitral valve prolapse...

This is the latest version of the MitraClip, the G4, which allows each side of the clip to be opened and closed independently to offer more flexibility when capturing the valve leaflets. The device is being used in the REPAIR MR clinical trial.

This is the latest version of the MitraClip, the G4, which allows each side of the clip to be opened and closed independently to offer more flexibility when capturing the valve leaflets. The device is being used in the REPAIR MR clinical trial. 

News | Heart Valve Technology | January 13, 2020

January 13, 2020 — The U.S. Food and Drug Administration (FDA) has approved clinical trial that will compare the...

This photo is from a MitraClip procedure during the University of Colorado visit last December.

Ten out of the top 25 videos in 2019 are from hospital site visits DAIC conducted and shot more than 10 video interviews and recorded cath lab procedures at each center.  Two of the videos here are walk throughs of cath labs, showing how Henry Ford Hospital and the University of Colorado set up their main hybrid rooms for structural heart procedures. This photo is from a MitraClip procedure during the University of Colorado visit last December.

Feature | December 30, 2019 | Dave Fornell, Editor

Here are the top performing 25 videos posted to the DAIC website in the past year, based on Google Analytics. These...

The Wyss Translational Center in Zurich, Switzerland has developed the LifeMatrix platform to engineer tissues that can be implanted in patients and will grow with them. This technology is being developed for heart valves in younger patients to eliminate the need for repeat surgeries to implant larger prosthetic heart valves as the patient grows.

The Wyss Translational Center in Zurich, Switzerland has developed the LifeMatrix platform to engineer tissues that can be implanted in patients and will grow with them. This technology is being developed for heart valves in younger patients to eliminate the need for repeat surgeries to implant larger prosthetic heart valves as the patient grows.

 

News | Heart Valve Technology | December 26, 2019

While transcatheter heart valve replacement and repair devices are growing in popularity due to their delivery and...

The most popular content in the month of November on DAIC was by far the data from the late-breaking trials from the American Herart Association (AHA) 2019 meeting. The second item on this month's list is an overview of key heart failure takeaways from AHA by Nasrien Ibrahim, M.D., associate director of resynchronization and advanced cardiac therapeutics at Massachusetts General Hospital.  Photo by Scott Morgan/AHA.

The most popular content in the month of November on DAIC was by far the data from the late-breaking trials from the American Herart Association (AHA) 2019 meeting. The second item on this month's list is an overview of key heart failure takeaways from AHA by Nasrien Ibrahim, M.D., associate director of resynchronization and advanced cardiac therapeutics at Massachusetts General Hospital.  Photo by Scott Morgan/AHA. 

Feature | December 17, 2019

December 16, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (...

A sample of the transcatheter mitral valve replacement (TMVR) devices in development or clinical trials.

A sample of the transcatheter mitral valve replacement (TMVR) devices in development or clinical trials.

Feature | Heart Valve Technology | November 27, 2019 | Saipriya Iyer

The overwhelming success story for transcatheter aortic valve replacement (TAVR) moving from a science project to...

A key slide from the TRILUMINATE study one-year results showing the improvement in tricuspid regurgitation from basement with treatment using the transcatheter TriClip device.

A key slide from the TRILUMINATE study one-year results showing the improvement in tricuspid regurgitation from basement with treatment using the transcatheter TriClip device.

News | Heart Valve Technology | November 26, 2019 | Dave Fornell, Editor

November 26, 2019 — The preliminary one-year results of the TRILUMINATE Pivotal Study for Abbott's TriClip device, a...

The American Heart Association, AHA, 2019 meeting late breaking trials and key studies on cardiovascular science.
Feature | AHA | November 19, 2019 | Dave Fornell, Editor

November 19, 2019 — Here is a list of the key late-breaking clinical study presentations and links to the results at...

One of the cardiology technologies in the list of top advances in 2019 is Medtronic’s Tyrx Absorbable Antibacterial Envelope using to enclose cardiac implantable electronic devices (CIEDs). It reduced the risk of major infection by 40 percent, and pocket infection by 61 percent, based on data presented at ACC 2019.

One of the cardiology technologies in the list of top advances in 2019 is Medtronic’s Tyrx Absorbable Antibacterial Envelope using to enclose cardiac implantable electronic devices (CIEDs). It reduced the risk of major infection by 40 percent, and pocket infection by 61 percent, based on data presented at ACC 2019.

News | November 06, 2019

November 6, 2019 — Cleveland Clinic announced the Top 10...

Edwards Sapien 3 TAVI Granted European Approval to Treat Low-risk Patients. TAVR cleared for low risk patients in Europe
Feature | November 06, 2019

November 6, 2019 — Edwards Lifesciences announced it received European CE mark to expand use of the Edwards Sapien 3...

The first all-women panel discussion on structrual heart cases was held at TCT 2019. Rebecca Hahn, M.D., foreground, was the co-organizer of the Women in Structural Heart (WISH) evening session.

The first all-women panel discussion on structrual heart cases was held at TCT 2019. Rebecca Hahn, M.D., foreground, was the co-organizer of the Women in Structural Heart (WISH) evening session.

Blog | Structural Heart | November 04, 2019

My observation over the 13 years covering cardiology is that it is a heavily male-dominated field. This is more...

EchoPixel showed technology at TCT 2019 that creates live holograms in the cath lab from 3-D TEE imaging. It projects the holograms on a special display screen that does not require the user to wear 3-D glasses. The interventional cardiologist can use hand movements and a foot switch to move the image around without breaking the sterile field. It offers a new way to visualize catheters, device positioning and deployment for structural heart procedures. #TCT2019 #TCT #TCT19

EchoPixel showed technology at TCT 2019 that creates live holograms in the cath lab from 3-D TEE imaging. It projects the holograms on a special display screen that does not require the user to wear 3-D glasses. The interventional cardiologist can use hand movements and a foot switch to move the image around without breaking the sterile field. It offers a new way to visualize catheters, device positioning and deployment in structural heart procedures. (Photos by Dave Fornell)

Feature | TCT | November 04, 2019 | Dave Fornell, Editor

The latest in interventional cardiology clinical data and new device technologies were highlighted at the annual...

Former National Football League (NFL) player Ed White (left) needed a new aortic heart valve but decided to wait several months for the FDA to approve TACR for low-risk patients so he would not have to undergo open heart surgery. Democratic presidential candidate Sen. Bernie Sanders received two stents after he was hospitalized with chest pain was hospitalized with chest pain on Oct. 1 in Las Vegas. The event brought PCI to the forefront of national news in October.

Former National Football League (NFL) player Ed White (left) needed a new aortic heart valve, but decided to wait several months for the FDA to approve TAVR for low-risk patients so he would not have to undergo open heart surgery. Democratic presidential candidate Sen. Bernie Sanders received two stents after he was hospitalized with chest pain was hospitalized with chest pain on Oct. 1 in Las Vegas. The event brought PCI to the forefront of national news in October. 

Feature | November 01, 2019 | Dave Fornell, Editor

November 1, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (...

 Retired National Football League (NFL) star Ed White, the former Chargers guard and four-time Pro Bowler, waited until the FDA approved TAVR for low-risk patients like himself to avoid open-heart surgery.

Retired National Football League (NFL) star Ed White, the former Chargers guard and four-time Pro Bowler, waited until the FDA approved TAVR for low-risk patients like himself to avoid open-heart surgery.

Feature | Heart Valve Technology | October 29, 2019

October 29, 2019 — When Scripps cardiologists discovered early in 2019 that retired National Football League (NFL)...

Overlay Init